ELISA/ACT Biotechnologies LLC

Lymphocyte Response Assay (LRA) by ELISA/ACT^® tests provide patient-specific information about all delayed hypersensitivity (DTH) / delayed allergy pathways. Our proprietary tests can be coupled with unique, individualized treatment interpretation guides to facilitate sustained remissions. The approach is based on proven clinical RCT controlled trials or case studies in managing people with chronic autoimmune and immune dysfunction syndromes.

A Welcome Letter from Dr. Russell M. Jaffe Founder, Lab Director, and CEO

These tests are unique because they are:

comprehensive and patient specific

ex vivo (cells react just as they do in the body)

functional (actual cell reactions to pure challenge items).

The treatment guide addresses the causes (rather than the symptoms) and includes recommendations to facilitate remission and recovery.

Identifying the patient’s specific sensitivities (delayed allergies), those that burden the immune system, is a clinical breakthrough. Patients experience a dramatic improvement in the quality of their life as a result of treatment protocols developed and clinically validated by ELISA/ACT Biotechnologies LLC (EAB).

Phone: 1.800.553.5472 • E-mail: clientservices@elisaact.com • Search the Site •